Literature DB >> 23288320

Directed differentiation of human pluripotent cells to neural crest stem cells.

Laura Menendez1, Michael J Kulik, Austin T Page, Sarah S Park, James D Lauderdale, Michael L Cunningham, Stephen Dalton.   

Abstract

Multipotent neural crest stem cells (NCSCs) have the potential to generate a wide range of cell types including melanocytes; peripheral neurons; and smooth muscle, bone, cartilage and fat cells. This protocol describes in detail how to perform a highly efficient, lineage-specific differentiation of human pluripotent cells to a NCSC fate. The approach uses chemically defined media under feeder-free conditions, and it uses two small-molecule compounds to achieve efficient conversion of human pluripotent cells to NCSCs in ~15 d. After completion of this protocol, NCSCs can be used for numerous applications, including the generation of sufficient cell numbers to perform drug screens, for the development of cell therapeutics on an industrial scale and to provide a robust model for human disease. This protocol can be also be applied to patient-derived induced pluripotent stem cells and thus used to further the knowledge of human disease associated with neural crest development, for example, Treacher-Collins Syndrome.

Entities:  

Mesh:

Year:  2013        PMID: 23288320     DOI: 10.1038/nprot.2012.156

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  13 in total

Review 1.  Multipotentiality of the neural crest.

Authors:  Nicole M Le Douarin; Elisabeth Dupin
Journal:  Curr Opin Genet Dev       Date:  2003-10       Impact factor: 5.578

2.  Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells.

Authors:  Laura Menendez; Tatiana A Yatskievych; Parker B Antin; Stephen Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Derivation of neural crest cells from human pluripotent stem cells.

Authors:  Gabsang Lee; Stuart M Chambers; Mark J Tomishima; Lorenz Studer
Journal:  Nat Protoc       Date:  2010-03-18       Impact factor: 13.491

4.  The teratoma assay: an in vivo assessment of pluripotency.

Authors:  Robin L Wesselschmidt
Journal:  Methods Mol Biol       Date:  2011

5.  Ectodermal Wnt function as a neural crest inducer.

Authors:  Martín I García-Castro; Christophe Marcelle; Marianne Bronner-Fraser
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

6.  PA6-induced human embryonic stem cell-derived neurospheres: a new source of human peripheral sensory neurons and neural crest cells.

Authors:  Oz Pomp; Irina Brokhman; Lina Ziegler; Mara Almog; Alon Korngreen; Manuela Tavian; Ronald S Goldstein
Journal:  Brain Res       Date:  2008-07-16       Impact factor: 3.252

Review 7.  Assembling neural crest regulatory circuits into a gene regulatory network.

Authors:  Paola Betancur; Marianne Bronner-Fraser; Tatjana Sauka-Spengler
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

8.  Order and coherence in the fate map of the zebrafish nervous system.

Authors:  K Woo; S E Fraser
Journal:  Development       Date:  1995-08       Impact factor: 6.868

9.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

10.  Tissue targeted embryonic chimeras: zebrafish gastrula cell transplantation.

Authors:  Elizabeth R Deschene; Michael J Barresi
Journal:  J Vis Exp       Date:  2009-09-11       Impact factor: 1.355

View more
  82 in total

Review 1.  Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.

Authors:  Xixi Du; Jack M Parent
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  A robust method to derive functional neural crest cells from human pluripotent stem cells.

Authors:  Faith R Kreitzer; Nathan Salomonis; Alice Sheehan; Miller Huang; Jason S Park; Matthew J Spindler; Paweena Lizarraga; William A Weiss; Po-Lin So; Bruce R Conklin
Journal:  Am J Stem Cells       Date:  2013-06-30

Review 3.  Pluripotent stem cells for Schwann cell engineering.

Authors:  Ming-San Ma; Erik Boddeke; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 4.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

5.  EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome.

Authors:  Emily E Miller; Gerson S Kobayashi; Camila M Musso; Miranda Allen; Felipe A A Ishiy; Luiz Carlos de Caires; Ernesto Goulart; Karina Griesi-Oliveira; Roseli M Zechi-Ceide; Antonio Richieri-Costa; Debora R Bertola; Maria Rita Passos-Bueno; Debra L Silver
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

Review 6.  Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.

Authors:  Priya Srikanth; Tracy L Young-Pearse
Journal:  J Neurogenet       Date:  2014-03-17       Impact factor: 1.250

7.  Chemical ablation of tumor-initiating human pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

Review 8.  Application of iPS cells in dental bioengineering and beyond.

Authors:  Pengfei Liu; Yanmei Zhang; Shubin Chen; Jinglei Cai; Duanqing Pei
Journal:  Stem Cell Rev Rep       Date:  2014-10       Impact factor: 5.739

Review 9.  Specifying neural crest cells: From chromatin to morphogens and factors in between.

Authors:  Crystal D Rogers; Shuyi Nie
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2018-05-03       Impact factor: 5.814

10.  Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.

Authors:  Sara Nolbrant; Andreas Heuer; Malin Parmar; Agnete Kirkeby
Journal:  Nat Protoc       Date:  2017-08-31       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.